Taiwan Advanced Nanotech Inc. (TPEX:6797)
Taiwan
· Delayed Price · Currency is TWD 15.00
0.00 (0.00%)
Apr 29, 2026, 1:38 PM CST
Taiwan Advanced Nanotech Revenue
In the year 2025, Taiwan Advanced Nanotech had annual revenue of 154.37M TWD, down -21.87%. Taiwan Advanced Nanotech had revenue of 87.49M in the half year ending December 31, 2025, a decrease of -18.49%.
Revenue
154.37M
Revenue Growth
-21.87%
P/S Ratio
2.80
Revenue / Employee
n/a
Employees
n/a
Market Cap
432.92M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 154.37M | -43.22M | -21.87% |
| Dec 31, 2024 | 197.59M | -48.02M | -19.55% |
| Dec 31, 2023 | 245.61M | -1.08B | -81.48% |
| Dec 31, 2022 | 1.33B | -601.86M | -31.21% |
| Dec 31, 2021 | 1.93B | 209.31M | 12.18% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Health & Life | 398.05M |
| EPS Bio Technology | 499.70M |
| AmCad BioMed | 30.44M |
| Radiant Innovation | 387.58M |
| iXensor | 26.88M |
| S&S Healthcare Holding | 204.21M |
| PlexBio | 127.10M |
| Wiltrom | 311.77M |